ARVN
Arvinas Inc
Price:  
7.43 
USD
Volume:  
807,030.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-116.6%
Upside

As of 2026-10-02, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -28.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 385.38 mil USD. Arvinas's TTM EBITDA according to its financial statements is -13.70 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.7x - 15.9x 11.4x
Forward P/E multiples 11.7x - 15.5x 14.0x
Fair Price (1.02) - (1.84) (1.23)
Upside -113.8% - -124.8% -116.6%
7.43 USD
Stock Price
(1.23) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-30 -29.57
2026-09-29 -28.46
2026-09-28 -28.51
2026-09-25 -28.88
2026-09-24 -29.83
2026-09-23 -30.01
2026-09-22 -33.22
2026-09-21 -32.23
2026-09-18 -32.18
2026-09-17 -32.27
2026-09-16 -31.57
2026-09-15 -32.04
2026-09-14 -32.70
2026-09-11 -32.93
2026-09-10 -34.16
2026-09-09 -34.39
2026-09-08 -35.90
2026-09-04 -37.36
2026-09-03 -36.98
2026-09-02 -38.30
2026-09-01 -36.84
2026-08-31 -36.47
2026-08-28 -36.37
2026-08-27 -36.65
2026-08-26 -37.03
2026-08-25 -38.35
2026-08-24 -37.13
2026-08-21 -37.24
2026-08-20 -35.64
2026-08-19 -38.73
2026-08-18 -36.75
2026-08-17 -36.47
2026-08-14 -35.38
2026-08-13 -35.57
2026-08-12 -34.91
2026-08-11 -35.48
2026-08-10 -35.48
2026-08-07 -34.35
2026-08-06 -34.02
2026-08-05 -32.70
2026-08-04 -35.52
2026-08-03 -31.10
2026-07-31 -30.96
2026-07-30 -32.23
2026-07-29 -31.85
2026-07-28 -31.76
2026-07-27 -31.85
2026-07-24 -30.96
2026-07-23 -31.38
2026-07-22 -32.04